This is the authors' abstract. We don't add key points for this paper.
Traditionally, the liver transplantation outcomes of interest to both clinicians and researchers have been survival rates and postoperative complications. For patients, however, the decision to have a liver transplant is often made in an effort to improve their quality of life and to reduce their risk of mortality and morbidity. Measurement of health-related quality of life (HRQL) has become a large area of research in the past few decades across the full spectrum of patient groups. In addition to scientific interest in HRQL, clinicians have increasingly become interested in how liver transplantation may affect not only patients' quantity of life but also their quality of life. Some research has investigated the quality of life of liver transplant patients, focusing largely on comparisons between quality-of-life domains of patients before transplantation and shortly after transplantation.1-5 The investigated posttransplantation period is typically within a year and less frequently within the first few years after the transplant. In one such study, orthotopic liver transplantation (OLT) was associated with significant improvement in a number of HRQL domains. In fact, this rapid improvement in HRQL was associated with better resource utilization.5 Additionally, in a recent meta-analysis, Bravata and colleagues6 reported data on HRQL of liver transplant recipients. They concluded that there generally were improvements in patients' general health, physical health, daily activity functioning, and sexual functioning after transplantation. There was less consistent evidence of improvement in psychological health, however, including social isolation and social functioning. These findings are consistent with studies of recipients of other organ transplants (for example, lung, kidney, and heart transplants), which have found that the posttransplantation quality of life of organ recipients is better than their pretransplantation quality of life, particularly in physical health domains.7 HRQL, health-related quality of life; OLT, orthotopic liver transplantation. Desai et al.'s study8 in this issue of Liver Transplantation provides valuable cross-sectional information on the quality of life of patients at least 10 years (and up to 30 years) after they underwent liver transplantation. Their patient population consists of 57 residents in the United Kingdom who received a liver transplant between 1968 and 1994 and completed a mail survey asking about their quality of life. Additionally, a wide range of clinical and demographic data was retrospectively collected. This study is one of the first to provide quality-of-life data over a decade after patients received organ transplantation. Not only is little known about the long-term physical and psychological benefits of liver transplants, but it is uncommon to have long-term data on any population group because it is time-consuming and cost-prohibitive to follow up with patient groups over many years. One of the greatest strengths of this study by Desai et al.8 is that they used both a generic (global) HRQL measure and a disease-specific HRQL measure. The generic instrument, the SF-36, which is a widely used 8-domain HRQL instrument, allows for comparisons in quality of life to be made across patient groups, including long-term HRQL outcomes of other organ transplant patients.9 The Ferrans and Powers Questionnaire, on the other hand, was designed to assess the HRQL of liver transplant recipients and therefore provides more specific data.10 Evidence from both instruments demonstrates that 10 or more years after OLT, patients generally have better quality of life. Comparisons of patients' scores to those of the general population of the United Kingdom, using the SF-36 domains, indicate similar quality-of-life scores for general health, mental health, level of pain, vitality, and role emotion. Liver transplant patients' physical functioning and role physical scores, however, were lower than the general population norms. Obtaining quality-of-life data on both generic and disease-specific levels allowed the investigators to have a more well-rounded understanding of patients' experiences and provided additional evidence supporting the positive long-term impact of liver transplantation on quality of life. The researchers unfortunately did not have pretransplantation or short-term posttransplantation quality-of-life data available for these patients. Having such data would have provided a much better sense of how quickly liver transplantation can positively impact patients' quality of life. Nevertheless, the study does provide some long-term data supporting the evidence that after liver transplantation most of the HRQL domains will return close to population norms. In addition to longitudinal data with multiple HRQL assessments, a number of other issues should be considered for future research. Although Desai et al.8 make a cross-sectional comparison of liver transplant recipients' HRQL to that of the general population, it would have been interesting to have comparative data pre-OLT or shortly after OLT with the same instruments. It would have also been valuable, despite the small sample size, to provide some psychometric information on the HRQL domains measured because little is known about the HRQL of this patient group in the long term. For instance, how valid and reliable are these measures with this patient group? The results are difficult to follow in this article because there is little explanation of how the analyses were undertaken and only limited data are presented in the tables and graphs. It is unclear, for example, why binary logistic regression was used because none of the SF-36 or Ferrans and Powers instrument scales are dichotomous. Furthermore, more descriptive data on each of the quality-of-life scales could have been included, given that little is known about this patient group many years after transplantation. Nevertheless, the authors provide an interesting discussion about the possible explanations for why some clinical and personal factors influenced different quality-of-life domains. However, they do not adequately explore possible reasons why patients' physical functioning may be poorer in comparison with the general population but their scores did not differ for many other domains, including general health. This is a particularly important area for future research because studies investigating pretransplantation and short-term posttransplantation quality-of-life scores among liver transplant patients have found that mental health dimensions are less likely to improve and are lower than those of the general population.6 One explanation for the findings in this study may be that a type II error occurred because of the relatively small sample size (n = 57). Despite these shortcomings, this study provides valuable long-term HRQL data after liver transplantation. Given the importance of HRQL for transplant patients, future studies of this patient population must assess HRQL outcomes in a systematic fashion with validated HRQL instruments.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dan et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: